Drugs Made In America Acquisition Rights Current Cash

Drugs Made In America Acquisition Rights (DMAAR) currently reports a current cash of $20K as of June 2026. That compares with $820 in the prior-year period — up 2367.2% year over year. Use the charts on this page to explore Drugs Made In America Acquisition Rights's current cash history and peer comparisons.

Drugs Made In America Acquisition Rights's current cash increased from $820 to $20K — a 2367.2% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Drugs Made In America Acquisition Rights reported $20K in current cash as of June 2026. That compares with $820 in the prior-year period — up 2367.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $20K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Drugs Made In America Acquisition Rights, and consider following DMAAR for alerts when major investors trade the stock.